Obesity and renal disease.

Area of Science:

• Nephrology
• Obesity Medicine
• Pathophysiology

Background:

• Obesity is an epidemic, frequently complicating with hypertension and renal issues like proteinuria.
• Obesity-associated proteinuria presents with focal glomerulosclerosis and glomerulomegaly, often without significant edema or hypertension, but can lead to end-stage renal disease.
• Severe obesity exacerbates pre-existing kidney conditions or reduced renal mass.

Purpose of the Study:

• To explore the pathophysiology of obesity-associated proteinuria.
• To identify key factors contributing to kidney damage in obese patients.
• To highlight therapeutic strategies for obesity-associated proteinuria.

Main Methods:

• Review of clinical presentation and biopsy findings in patients with obesity-associated proteinuria.
• Analysis of potential pathophysiological mechanisms including hyperfiltration and growth factor involvement.
• Evaluation of therapeutic interventions.

Main Results:

• Patients exhibit specific glomerular changes (focal glomerulosclerosis, glomerulomegaly) and can progress to kidney failure.
• Pathophysiology involves hyperfiltration, glomerular hypertrophy, hyperlipidemia, and increased vasoactive/fibrogenic substances (e.g., angiotensin II, leptin).
• Angiotensin-converting enzyme inhibition may offer temporary benefit.

Conclusions:

• Obesity-associated proteinuria is a serious complication of obesity with distinct pathological features.
• Multiple factors contribute to the kidney damage, including hemodynamic and hormonal changes.
• Weight reduction is the primary therapeutic strategy for managing obesity-associated proteinuria.